Classifying new anti-tuberculosis drugs: rationale and future perspectives

Simon Tiberi, Anna Scardigli, Rosella Centis, Lia D'Ambrosio, Marcela Muñoz-Torrico, Miguel Ángel Salazar-Lezama, Antonio Spanevello, Dina Visca, Alimuddin Zumla, Giovanni Battista Migliori, Jose A Caminero Luna

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Classifying new anti-tuberculosis drugs: rationale and future perspectives'. Together they form a unique fingerprint.

Medicine & Life Sciences